CVR number 41726792
Industry 86.2300 Dental practice activities

Tandlægeselskabet Tandlægen.dk - Brønderslev ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  7.2% 11.4% 21.6% 14.1% 8.2%  
Credit score (0-100)  33 20 4 15 30  
Credit rating  BBB BB B BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  1,751 7,313 8,385 11,482 11,767  
EBITDA  -258 -428 -465 635 700  
EBIT  -258 -428 -465 635 700  
Pre-tax profit (PTP)  -261.5 -444.2 -470.9 584.5 707.9  
Net earnings  -204.0 -347.1 -618.6 698.4 549.9  
Pre-tax profit without non-rec. items  -262 -444 -471 585 708  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -124 -471 -1,090 -391 159  
Interest-bearing liabilities  343 350 595 405 349  
Balance sheet total (assets)  1,929 1,454 467 1,266 1,773  
Net Debt  -1,177 -615 494 -296 -561  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,751 7,313 8,385 11,482 11,767  
Gross profit growth  -76.1% 317.6% 14.7% 36.9% 2.5%  
Employees  15 13 13 14 15  
Employee growth %  15.4% -13.3% 0.0% 7.7% 7.1%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,929 1,454 467 1,266 1,773  
Balance sheet change%  32.6% -24.6% -67.9% 171.2% 40.1%  
Added value  -257.6 -428.2 -465.4 634.9 700.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 -4.0 1.0 2.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -14.7% -5.9% -5.5% 5.5% 6.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -12.9% -21.3% -26.3% 40.2% 42.5%  
ROI %  -74.3% -122.1% -96.7% 129.2% 157.3%  
ROE %  -12.1% -20.5% -64.4% 80.6% 77.2%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -6.1% -24.6% -70.2% -24.1% 9.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  456.7% 143.6% -106.2% -46.7% -80.1%  
Gearing %  -276.9% -74.4% -54.6% -103.4% 220.1%  
Net interest  0 0 0 0 0  
Financing costs %  1.2% 6.0% 2.9% 12.3% 5.4%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.1 0.9 0.3 0.9 1.3  
Current Ratio  1.1 0.9 0.4 0.9 1.3  
Cash and cash equivalent  1,520.0 965.0 100.7 700.7 910.1  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  200.7 -139.6 -749.7 -69.7 449.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -17 -33 -36 45 47  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -17 -33 -36 45 47  
EBIT / employee  -17 -33 -36 45 47  
Net earnings / employee  -14 -27 -48 50 37